摘要
目的:探讨布地奈德联合特布他林雾化吸入在儿童支气管哮喘治疗中的应用效果。方法:选取笔者所在医院2014年10月-2016年10月收治的238例支气管哮喘急性发作住院患儿随机分为研究组和对照组,每组119例,对照组进行常规对症支持治疗,研究组在此基础上给予布地奈德与特布他林雾化吸入,观察两组患儿呼吸困难、咳嗽和肺部哮鸣音等临床症状体征消失平均时间和平均住院时间,并进行疗效判定。结果:研究组患儿呼吸困难、咳嗽和肺部哮鸣音等临床症状体征消失平均时间和平均住院时间均明显短于对照组,差异均有统计学意义(P<0.05);研究组临床总有效率为91.60%,对照组临床总有效率为69.75%,研究组显著高于对照组,差异有统计学意义(P<0.05)。结论:布地奈德联合特布他林雾化吸入在儿童支气管哮喘急性发作治疗中的疗效确切,值得在临床推广应用。
Objective：To explore the application effect of Budesonide combined with Terbutaline inhalation in treatment of children with bronchial asthma.Method：From October 2014 to October 2016,238 cases with acute bronchial asthma treated in our hospital were randomly divided into study group and control group,119 cases in each group.The control group were given routine symptomatic and supportive treatment.On the basis of this,the research group were given Budesonide and Terbutaline inhalation.The clinical symptoms such as dyspnea,cough and wheezing of children were observed in two groups,and the average signs disappeared time and the average hospitalization time were observed to determine the efficacy.Result：The clinical symptoms such as dyspnea,cough and other symptoms of the study group were significantly shorter than those of the control group,and the wheezing and other signs disappeared time and average hospitalization time were significantly shorter than those of the control group,the differences were statistically significant（P〈0.05）.The clinical total effective rate in the study group was 91.60%,which was higher than 69.75% in the control group,the difference was statistically significant（P〈0.05）.Conclusion：Budesonide combined with Terbutaline inhalation in children with acute exacerbation of bronchial asthma is effective in treatment,which is worth in the clinical application.
出处
《中外医学研究》
2018年第1期23-24,共2页
CHINESE AND FOREIGN MEDICAL RESEARCH
